These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2576237)

  • 1. ras gene mutations and clonal analysis using RFLPs of X-chromosome genes in myelodysplastic syndromes.
    Janssen JW; Buschle M; Layton M; Lyons J; Bartram CR
    Haematol Blood Transfus; 1989; 32():386-9. PubMed ID: 2576237
    [No Abstract]   [Full Text] [Related]  

  • 2. Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin.
    Janssen JW; Buschle M; Layton M; Drexler HG; Lyons J; van den Berghe H; Heimpel H; Kubanek B; Kleihauer E; Mufti GJ
    Blood; 1989 Jan; 73(1):248-54. PubMed ID: 2562924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of ras oncogene mutation in a myelodysplastic syndrome after low-dose cytarabine therapy.
    Layton DM; Mufti GJ; Lyons J; Janssen JW; Bartram CR
    N Engl J Med; 1988 Jun; 318(22):1468-9. PubMed ID: 3285212
    [No Abstract]   [Full Text] [Related]  

  • 4. Codon 12 ras mutations in patients with myelodysplastic syndrome: incidence and prognostic value.
    Constantinidou M; Chalevelakis G; Economopoulos T; Koffa M; Liloglou T; Anastassiou C; Yalouris A; Spandidos DA; Raptis S
    Ann Hematol; 1997 Jan; 74(1):11-4. PubMed ID: 9031609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).
    Fidler C; Watkins F; Bowen DT; Littlewood TJ; Wainscoat JS; Boultwood J
    Haematologica; 2004 Jul; 89(7):865-6. PubMed ID: 15257941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in ras genes in myelocytic leukemias and myelodysplastic syndromes.
    Bartram CR
    Blood Cells; 1988; 14(2-3):533-8. PubMed ID: 3067784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [N-ras and fms gene mutation in idiopathic thrombocytopenic purpura and myelodysplasia].
    Zhao HY; Hou M; Li XF; Ma DX; Liu QJ; Wang P
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):158-60. PubMed ID: 18788612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia.
    Vasioukhin V; Anker P; Maurice P; Lyautey J; Lederrey C; Stroun M
    Br J Haematol; 1994 Apr; 86(4):774-9. PubMed ID: 7918071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloid leukemia: analysis of ras gene mutations and clonality defined by polymorphic X-linked loci.
    Bartram CR; Ludwig WD; Hiddemann W; Lyons J; Buschle M; Ritter J; Harbott J; Fröhlich A; Janssen JW
    Leukemia; 1989 Apr; 3(4):247-56. PubMed ID: 2564452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming genes and chromosome aberrations in therapy-related leukemia and myelodysplastic syndrome.
    Inokuchi K; Amuro N; Futaki M; Dan K; Shinohara T; Kuriya S; Okazaki T; Nomura T
    Ann Hematol; 1991 Jun; 62(6):211-6. PubMed ID: 1854883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic studies, ras mutation, and clinical characteristics in primary myelodysplastic syndrome. A study on 68 Chinese patients in Taiwan.
    Tien HF; Wang CH; Chuang SM; Chow JM; Lee FY; Liu MC; Chen YC; Shen MC; Lin DT; Lin KH
    Cancer Genet Cytogenet; 1994 May; 74(1):40-9. PubMed ID: 8194046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic abnormalities in the myelodysplastic syndrome.
    Jacobs A
    Acta Haematol Pol; 1991; 22(2):197-202. PubMed ID: 1841492
    [No Abstract]   [Full Text] [Related]  

  • 13. Clonality in myelodysplastic syndromes: demonstration of pluripotent stem cell origin using X-linked restriction fragment length polymorphisms.
    Tsukamoto N; Morita K; Maehara T; Okamoto K; Karasawa M; Omine M; Naruse T
    Br J Haematol; 1993 Apr; 83(4):589-94. PubMed ID: 8100140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of N-ras mutation in a patient with AML M4 and trilineage myelodysplasia.
    Vandenberghe E; Baens M; Stul M; Bosly A; Cassiman JJ; Mecucci C; Van den Berghe H
    Br J Haematol; 1991 Oct; 79(2):338-40. PubMed ID: 1958496
    [No Abstract]   [Full Text] [Related]  

  • 15. Low frequency of NRAS and KRAS2 gene mutations in childhood myelodysplastic syndromes.
    Jekic B; Novakovic I; Lukovic L; Kuzmanovic M; Popovic B; Pastar I; Milasin J; Bunjevacki G; Bunjevacki V
    Cancer Genet Cytogenet; 2004 Oct; 154(2):180-2. PubMed ID: 15474158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the ras proto-oncogenes in patients with myelodysplastic syndromes.
    Neubauer A; Greenberg P; Negrin R; Ginzton N; Liu E
    Leukemia; 1994 Apr; 8(4):638-41. PubMed ID: 7512175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene mutations in myelodysplasia.
    Jacobs A
    Leuk Res; 1992; 16(1):47-50. PubMed ID: 1732670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic aspects of myelodysplastic syndromes.
    Bartram CR
    Hematol Oncol Clin North Am; 1992 Jun; 6(3):557-70. PubMed ID: 1613006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-ras mutation in chemically induced rat brain tumour.
    Rády P; Kinsella AR; Fox M; Arany I; Kertai P
    Acta Biochim Biophys Hung; 1989; 24(4):313-6. PubMed ID: 2577259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetic aspects of myelodysplastic syndromes.
    Bartram CR
    Semin Hematol; 1996 Apr; 33(2):139-49. PubMed ID: 8722684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.